Urolithiasis device market seen reaching $2.21 billion by 2030

The market for urolithiasis management devices is projected to grow from $1.79 billion in 2026 to $2.21 billion by 2030, driven by rising kidney stone cases, more minimally invasive procedures and expanding outpatient care. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Urolithiasis management devices are part of the expanding market for kidney stone treatment as demand rises for less invasive procedures and faster recovery. - The growth outlook points to more spending on urology tools, especially in settings that handle endoscopic stone removal and laser-based lithotripsy.

What happened: - The Business Research Company released its Urolithiasis Management Devices Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 on Sept. 2, 2026. - The report says the global market will rise from $1.69 billion in 2025 to $1.79 billion in 2026. - The report projects the market will reach $2.21 billion by 2030. - The report puts the forecast CAGR at 5.4% from 2026 to 2030. - Urolithiasis management devices are medical instruments used to diagnose, treat and manage kidney stones in the urinary tract. - The devices are used to break down, extract or help pass stones through minimally invasive methods. - A free sample of the report is available here. - The full report is available here.

The details: - Historical growth in the market is linked to rising kidney stone disease, more urology departments, wider use of endoscopic stone management, better lithotripsy technology and improved access to urological care. - Future growth is expected to come from demand for minimally invasive urology procedures, higher healthcare spending on specialized care, more ambulatory surgical centers and advances in laser lithotripsy. - The report also cites growing interest in outpatient urology treatments and procedures designed to improve treatment efficiency and patient outcomes. - The report says the market’s key trends include wider adoption of minimally invasive stone removal devices, increased use of laser-based lithotripsy systems and greater use of flexible ureteroscopes. - The analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis, future trend analysis, and updated graphics and tables.

Between the lines: - Rising chronic kidney disease appears to be an important demand driver because CKD can contribute to stone formation through mineral imbalances, impaired filtration and reduced waste elimination. - Kidney Research UK said in June 2023 that about 3.9 million people in the UK are expected to have CKD stages 3 to 5 by 2033. - North America held the largest market share in 2025, reflecting established healthcare infrastructure and advanced medical technology. - Asia-Pacific is expected to be the fastest-growing region as healthcare access expands, awareness rises and kidney stone disease becomes more common.

What's next: - The market’s next phase will likely center on outpatient care, minimally invasive devices and tools that improve speed and recovery. - Regional growth is expected to remain strongest in Asia-Pacific, while North America keeps a leading position. - The Business Research Company is offering direct expert contact through Saumya Sahay and its published phone numbers and email for follow-up.

The bottom line: - Kidney stone treatment is becoming more device-driven, and the market is on track to keep growing steadily through 2030.